Aegros founders John Manusu and Dr. Hari N. were interviewed by Seven Network yesterday at the official opening ceremony of the Aegros facility in Macquarie Park. The Company is looking forward to providing frontline health workers with immunity to COVID-19 until a vaccine is found. #plasmatherapy #covid19
Aegros
Biotechnology Research
Macquarie Park, NSW 14,961 followers
Australia's hyperimmune specialists and the nation's other fractionator.
About us
At Aegros we believe access to life saving therapeutic plasma drugs is a human right and not a privilege. Our mission is to put the patient first through innovation and we do this thanks to our Australian invented Haemafrac®, Aegros' unique electroseparation process. Our TGA GMP-approved plasma fractionation plant in Macquarie Park, Sydney, manufactures a hyperimmune immunoglobulin product against Covid-19, made from convalescent plasma. Aegros is currently undertaking the final preparations for the submission of a dossier for the registration of this hyperimmune against Covid-19 on the Australian Register of Therapeutic Goods (ARTG) Simultaneously, Aegros is finishing the upgrade of its existing hyperimmune facility at Macquarie Park NSW to be able to process 100,000l of plasma per year.
- Website
-
http://www.aegros.com.au
External link for Aegros
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Macquarie Park, NSW
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Therapeutic plasma products and Building of therapeutic plasma facilities
Locations
-
Primary
Get directions
5 Eden Park Drive
Macquarie Park, NSW 2113, AU
Employees at Aegros
-
Mike Swan
Chief Marketing Officer leading global commercialisation of plasma-derived therapeutics, immunotherapies, and protein separation technologies.
-
Dr. Ranjeet Ajmani
Plasma Fractionation and Blood Plasma Products
-
Damian Thornton
Redefining plasma fractionation through innovation
-
Fred Paraskevas
Head of Information Technology | Senior IT Manager | Project Management | Leadership | Vendor Management | ERP
Updates
-
Getting plasma derived medicines to the people who need them also involves knowledge sharing and developing the capability of plasma collections, donor and patient management, and regulatory schemes. Aegros is proud to be at the forefront of these conversations with our partners. #PDMPs #AfSBT
Partnering With Africa’s Blood Transfusion & Plasma Medicine Sectors
Aegros on LinkedIn
-
We're looking forward to the sold-out LSQ Future of Health seminar tomorrow. See you at Brookwater Golf & Country Club. #collaboration #biotechnology #bioparkaustralia
The Future of Health Is Tomorrow
Aegros on LinkedIn
-
Aegros Cofounder Professor Hari Nair looks forward to speaking at the first LSQ Future of Health event for 2024. If you are in biomanufacturing, then this is the event for you. Seats are filling fast so make sure you get your booking in soon! Read more for details #LSQ #BioParkAustralia
It’s Past Time To Be Present At The Future Of Health Series
Aegros on LinkedIn
-
Life with a rare disease can mean the uncertainty of a 10-year journey to diagnosis followed by a search for effective treatment options. Let's change this for the better. #CIPD #ASCIA #Immunedeficiency #Cancer
A Rare Disease Is A Journey Of Many Steps
Aegros on LinkedIn
-
Aegros was proud to show the progress we have made on the upgrade to our hyperimmune production facility to health decision makers, as well as playing hosting local business leaders.
Bennelong Business Leaders Meet Assistant Minister
Aegros on LinkedIn
-
The upgrade to Aegros' hyperimmune facility is a big project with big benefits for Australia. Watch as the future of plasma fractionation takes shape.
Upgrading Haemafrac® facility at Macquarie Park NSW: Jan-Feb time lapse footage
Aegros on LinkedIn
-
Aegros has convened a panel of leading experts to advise its Board of Directors. The first meeting of this panel was held recently, and all were impressed with the progress Aegros has made towards commercialisation.
Expert Strategic Advisors Like What They See
Aegros on LinkedIn
-
Thank you to all the AATM-AABB delegates who came to say hello to us at the Aegros stand. It was our privilege to be Diamond sponsors of this important conference and we look forward to our next opportunity to meet and support nations to meet your plasma medicine goals.
Aegros @ AATM-AABB – Thank You to All
Aegros on LinkedIn
-
Following our recent announcement of the results of the Aegros CHAT clinical trial, this video explains the trial results, addresses next steps in our pathway to commercialisation, updates you on the progress of our industry engagement, and our site upgrade activities.
Aegros Founders and CMO discuss CHAT clinical trial results
Aegros on LinkedIn